<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <channel>
    <title>SearchForVideo.com Cyclophosphamide RSS</title>
    <link>http://www.searchforvideo.com</link>
    <description>SearchForVideo.com Cyclophosphamide videos</description>
    <item>
      <title>Fda Approves Two New Indications For Rituxan...</title>
      <link>http://www.metacafe.com/watch/289667/fda_approves_two_new_indications_for_rituxan/</link>
      <description>FDA APPROVES TWO NEW INDICATIONS FOR RITUXAN&#195;&#402;&#194;&#8218;&#195;&#8218;&#194;&#174; (RITUXIMAB) IN PATIENTS WITH NON-HODGKIN&#195;&#402;&#194;&#162;&#195;&#8218;&#194;&#8364;&#195;&#8218;&#194;&#8482;S LYMPHOMA

The U.S. Food and Drug Administration (FDA) has approved two additional uses for Rituxan for patients with CD20-positive, B-cell non-Hodgkin's lymphoma (NHL).


One new indication for Rituxan is for first-line treatment of previously untreated patients with follicular NHL in combination with CVP (cyclophosphamide, vincristine and prednisolone) chemotherapy. 
The second new indication is for the treatment of low-grade NHL in patients with stable disease or who achieve a partial or complete response following first-line treatment with CVP chemotherapy. 

NHL is the sixth most fatal cancer in the U.S. and an estimated 360,000 Americans have NHL - more than 58,000 new cases are diagnosed annually. About 30 percent of those patients diagnosed have a slow-growing, but incurable (low-grade) form of the disease -- the most common type is called follicular lymphoma. Relapse is common in these patients, making the goal of treatment to delay disease progression for as long as possible.

The second new Rituxan indication represents a new approach to the treatment of NHL, enabling doctors to treat patients front-line with Rituxan, already one of the standard therapies for NHL, on an extended basis following a good response to upfront CVP chemotherapy. Studies showed that this treatment approach helped reduce the risk of disease progression, relapse or death in certain NHL patients.					 Ranked  2.34  / 5 | 1969 views |  1 comments  
					 
					 
						  Click here to watch the video   (04:36) 
						Submitted By: 						 MultiVu  
						Tags:
						 Rituxan &amp;nbsp; Non-hodgkins &amp;nbsp; Lymphoma &amp;nbsp; MultiVu &amp;nbsp; 25461 &amp;nbsp;						 
						Categories:  News &amp;amp; Events</description>
    </item>
    <item>
      <title>Fda Approves Herceptin&#174; for the Adjuvant Treatment of Her2-Posi</title>
      <link>http://www.metacafe.com/watch/334528/fda_approves_herceptin_for_the_adjuvant_treatment_of_her2_posi/</link>
      <description>-- HERCEPTIN REDUCED THE RISK OF BREAST CANCER RECURRENCE
BY 52 PERCENT IN PIVOTAL STUDIES --

-- ONLY TARGETED BIOLOGIC THERAPY APPROVED FOR USE IN ADJUVANT AND METASTATIC HER2-POSITIVE BREAST CANCER --

Genentech, Inc. announced today that the U.S. Food and Drug Administration (FDA) approved Herceptin (Trastuzumab) for the adjuvant treatment of HER2-positive node-positive breast cancer, as part of a treatment regimen containing doxorubicin, cyclophosphamide, and paclitaxel. The FDA approval was based on data from an interim joint analysis of more than 3,500 patients enrolled in two Phase III clinical trials.  These results showed that the addition of Herceptin to standard adjuvant therapy significantly reduced the risk of breast cancer recurrence, the primary endpoint of the studies, by 52 percent in women with HER2-positive breast cancer, compared to those patients who received standard adjuvant therapy alone.

Adjuvant therapy is given to women with early-stage (localized) breast cancer who have had initial treatment surgery with or without radiation therapy with the goal of reducing the risk of cancer recurrence and/or the occurrence of metastatic disease.					 Ranked  3.22  / 5 | 1172 views |  0 comments  
					 
					 
						  Click here to watch the video   (03:56) 
						Submitted By: 						 MultiVu  
						Tags:
						 Fda.approves &amp;nbsp; Herceptin &amp;nbsp; Adjuvant &amp;nbsp; Treatments &amp;nbsp; Node &amp;nbsp; Positive &amp;nbsp; Breasts &amp;nbsp; Cancer &amp;nbsp; Medicine &amp;nbsp; Illness &amp;nbsp; Documentaries &amp;nbsp;						 
						Categories:  News &amp;amp; Events</description>
    </item>
    <item>
      <title>OX40 INHIBITION OF TREG SUPPRESSION - IMMUNOTHERAPY OF CANCER - 2nd European Congress of Immunology</title>
      <link>http://youtube.com/?v=4TXK6PsN-ng</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>REGULATORY T CELLS IN CANCER AND THEIR SUPPRESSION AS A STRATEGY TO ENHANCE THE EFFICACY - CANCER</title>
      <link>http://youtube.com/?v=dBiLZXyxhp4</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES - IMMUNOTHERAPY OF CANCER</title>
      <link>http://youtube.com/?v=c3Uqy6_ifls</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>Getting off the Ground</title>
      <link>http://youtube.com/?v=_Rk4FN1wHG0</link>
      <description>Author:  JohnsHopkins  
					Keywords:   Johns Hopkins University   Johns Hopkins Hospital   cyclophosphamide   HiCy clinical trial   Robert Brodsky   Alvin Myerberg   autoimmune disorders   multiple sclerosis (MS  
					Added: November 2, 2009</description>
    </item>
    <item>
      <title>Low Cost Cytoxan () Now FDA Approved Pills Online</title>
      <link>http://www.google.ca/url?q=http://astropampa.com/recomendaciones-2/index%3Frx-mg%3D3113%2719%27)&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNHGzNlsxbxrs_womredvuAX2BirMQ</link>
      <description>Low Cost Cytoxan (Cyclophosphamide) Now, Buy Cyclophosphamide Online Without Rx, Cytoxan Online Without Prescription, Cytoxan (Cyclophosphamide ...  astropampa.com</description>
    </item>
    <item>
      <title>LOW-DOSE  TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES - IMMUNOTHERAPY OF CANCER</title>
      <link>http://www.google.ca/url?q=http://www.youtube.com/watch%3Fv%3Dc3Uqy6_ifls&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNHrZm1f8i4kGYRe2aZDrz-BMODXPA</link>
      <description>The 2nd European Congress of Immunology - Immunity for Life, Immunology for Health -- IMMUNOTHERAPY OF CANCER - LOW-DOSE CYCLOPHOSPHAMIDE ...  youtube.com</description>
    </item>
    <item>
      <title>Acute Therapies: Steroids, IVIG, Plasmaexchange and </title>
      <link>http://www.google.ca/url?q=http://video.google.com/videoplay%3Fdocid%3D-6520984212253897481&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNF90d3XN3wETXsXX57UBT5L-8Ebow</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium, Acute Therapies: Steroids, IVIG, Plasmaexchange and Cyclophosphamide, Benjamin M. Greenberg, MD, MHS  video.google.com</description>
    </item>
    <item>
      <title>High Dose  (HiCy) in Multiple Sclerosis</title>
      <link>http://www.google.ca/url?q=http://video.google.com/videoplay%3Fdocid%3D-7875556960908357407&amp;source=video&amp;vgc=rss&amp;usg=AFQjCNFA5fNsBH_EjRPLwseNHwg2Dr2t_w</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium, High Dose Cyclophosphamide in Multiple Sclerosis, Chitra Krishnan, MHS, Adam I. Kaplin, MD, PhD  video.google.com</description>
    </item>
    <item>
      <title>Acute Therapies</title>
      <link>http://xml.truveo.com/rd?i=4108881018&amp;a=rss&amp;p=7&amp;h=4b0143925193dcc:25096b67b5fc9d2cd5612671c2dc3903</link>
      <description>2004 Rare Neuroimmunologic Disorders Symposium Acute Therapies B. Weinshenker, MD Corticosteroids, Plasma Exchange, Cyclophosphamide</description>
    </item>
    <item>
      <title>&#22899;&#20154;&#32633;&#24739;~~~~&#30284;&#30151;~~~&#26032;&#34277;~~~&#21487;&#20445;~~~&#29983;&#32946;&#21147;</title>
      <link>http://xml.truveo.com/rd?i=1353638227&amp;a=rss&amp;p=6&amp;h=4b0143925193dcc:25096b67b5fc9d2cd5612671c2dc3903</link>
      <description>top of your life-threatening disease by using cyclophosphamide,  there is the potential for major side effects down the road from this drug,'" said Robert Spiera, MD, an associate attending rheumatologist at Hospital for Special Surgery in New York. "This study provides strong evidence that Rituxan works as well as cyclophosphamide, at least in terms of getting patients into remission, and over that acute hump of being very ill. And, we can treat patients without the likelihood of ...</description>
    </item>
    <item>
      <title>High Dose Cyclophosphamide (HiCy) in Multiple Sclerosis</title>
      <link>http://xml.truveo.com/rd?i=503021264&amp;a=rss&amp;p=4&amp;h=4b0143925193dcc:25096b67b5fc9d2cd5612671c2dc3903</link>
      <description>2008 Rare Neuroimmunologic Disorders Symposium,  High Dose Cyclophosphamide in Multiple Sclerosis, Chitra Krishnan, MHS, Adam I. Kaplin, MD, PhD</description>
    </item>
    <item>
      <title>LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES</title>
      <link>http://xml.truveo.com/rd?i=1538884378&amp;a=rss&amp;p=1&amp;h=4b0143925193dcc:25096b67b5fc9d2cd5612671c2dc3903</link>
      <description>Immunity for Life,  Immunology for Health &amp;#8212; IMMUNOTHERAPY OF CANCER - LOW-DOSE CYCLOPHOSPHAMIDE TREATMENT AUGMENTS ANTITUMOR IMMUNE RESPONSES AND TUMOR IMMUNOGENICITY IN RET TRANSGENIC MOUSE MELANOMA MODEL - Speaker: A. Sevko - ICC Berlin - 16.09.2009 ... wikumedia wikumedi@ Immunsystem Medizin Immunology Zink Congress Health Ern&#195;&#164;hrung Gesundheit Immunity Darmerkrankung Vitamin medicine Inkt cells Homeostasis Glycosphingolipid skint1 TGF-&#195;&#376; CD27 RORgt interferon-&#206;&#177; CD137 immunotherapy Tumor ...</description>
    </item>
    <item>
      <title>Hunter&#8217;s Last Dose!</title>
      <link>http://xml.truveo.com/rd?i=4107910167&amp;a=rss&amp;p=8&amp;h=4b03f0164ad0f44:6683732ec4c255b190253ee87cd3d7be</link>
      <description>Hunter getting his last dose of Cyclophosphamide chemo at Doernbechers Children&#226;&#8364;&#8482;s Hospital!!!!! YAY....conditioning for transplant is almost complete!!! www.healinghunter.com</description>
    </item>
    <item>
      <title>Cicatricial Pemphigoid Treatment</title>
      <link>http://xml.truveo.com/rd?i=4211859689&amp;a=rss&amp;p=10&amp;h=4b03f0164ad0f44:6683732ec4c255b190253ee87cd3d7be</link>
      <description>Dr. Wendy Levinbook,  MD discusses Cicatricial Pemphigoid Treatment. See more at www.dermnet.com PLEASE RATE AND COMMENT!!! Treatment of cicatricial pemphigoid is based on the severity of disease and on the site of involvement. Mild or localized disease can be treated with topical steroid preparations. Dapsone may also be tried. However, in severe cases, systemic glucocorticoids are often necessary. For resistant disease, an immuosuppressive agent such as cyclophosphamide or azathioprine may ...</description>
    </item>
    <item>
      <title>TAPPING NON-SELECTED LYMPHOCYTE POPULATIONS TO OBTAIN HIGH-AFFINITY TCR - CANCER</title>
      <link>http://youtube.com/?v=mtmaJpZvq0k</link>
      <description>Author:  WiKuMedia  
					Keywords:   wikumedia   wikumedi@   Immunsystem   Medizin   Immunology   Zink   Congress   Health   Ern&#195;&#164;hrung   Gesundheit   Immunity   Darmerkrankung   Vitamin   medicine   Inkt   cells   Homeostasis   Glycosphingolipid   skint1   TGF-&#195;&#376;   CD27   RORgt   interferon-&#206;&#177;   CD137   immunotherapy   Tumor   Leukemic   IL-21   lymphocytes   cytotoxic   immunosuppression   melanoma   hiv   aids   infection   antiviral   iris   NEOREACTIVITY   cancer   antigen   glycan   lymphocyte   high-affinity   ox40   immunotherapeutic   vaccine   cyclophosphamide   antitumor   immunogenicity   transgenic  
					Added: September 30, 2009</description>
    </item>
    <item>
      <title>Hunter's Last Dose!</title>
      <link>http://youtube.com/?v=Xk8VxLeBLWw</link>
      <description>Author:  Lenoredavis9  
					Keywords:   Cyclophosphamide   Chemotherapy  
					Added: June 13, 2009</description>
    </item>
    <item>
      <title>Immunotherapy for Prostate Cancer</title>
      <link>http://youtube.com/?v=gmaqBcoLgjk</link>
      <description>Author:  riemenschneider2  
					Keywords:   Immunotherapy   Prostate   Cancer   Rimenschneider   cryo   cryotherapy   cyclophosphamide   t-cells   psa   gleason   frequency   incontinence   impotence   cancer   cure   nocturia   hematuria   lupron   galil   vantas   endocare   duke   bahn   hogdon   radge   aaron   katz   gary   onik   jeffrey   cohen   cytoxan   pcri  
					Added: November 29, 2008</description>
    </item>
    <item>
      <title>High-Dose Cyclophosphamide: a cure for autoimmune disease?</title>
      <link>http://youtube.com/?v=QoWXnXgDpSQ</link>
      <description>Author:  ChrisHadMS  
					Keywords:   multiple   sclerosis   ms   hicy   high   dose   cyclophosphamide   cytoxan   revimmune   johns   hopkins   autoimmune   disease   cure  
					Added: July 16, 2008</description>
    </item>
    <item>
      <title>antimitotique chimiotherapie</title>
      <link>http://www.dailymotion.com/video/x6nvdt_antimitotique-chimiotherapie_tech</link>
      <description>Pemetrexed 500mg Carboplatine 50mg 450mg Vinorelbine 10mg 20mg 30mg 50mg Palitaxel 100mg 300mg Oxaliplatine 50mg 100mg 5-Fluorouracile 250mg 500mg Capecitabine 500mg Docetaxel 20mg 80mg...</description>
    </item>
  </channel>
</rss>
